SCHEMBL31322152

SCHEMBL31322152

C=CCOc1ccc(CCC(=O)CC(=O)CCc2ccc(OCC=C)c(OC)c2)cc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.66
ALOX5 P09917 1/20 0.64
OR51E2 Q9H255 1/20 0.64
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 5/20 0.55
CYP2D6 P10635 1/20 0.55
PPARA Q07869 1/20 0.51
POLB P06746 3/20 0.51
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
GAA P10253 2/20 0.50
KMT2A Q03164 2/20 0.50
G6PD P11413 1/20 0.50
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
F2RL1 P55085 1/20 0.49
PTGS1 P23219 1/20 0.48
NPC1 O15118 1/20 0.47
HSP90AA1 P07900 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11415896 0.90 LTA4H (0.60) LTA4HALOX5OR51E2KDM4EALDH1A1
SCHEMBL3691758 0.88 PPARA (0.62) LTA4HKDM4EALDH1A1CYP2D6PPARA
SCHEMBL11426661 0.87 LTA4H (0.58) LTA4HKDM4EALDH1A1CYP2D6POLB
SCHEMBL15721367 0.87 ALOX5 (0.58) LTA4HALOX5OR51E2ALDH1A1PPARA
SCHEMBL10820441 0.85 ALOX5 (0.55) LTA4HALOX5OR51E2ALDH1A1PPARA
SCHEMBL10307841 0.84 ALOX5 (0.77) ALOX5OR51E2KDM4EALDH1A1POLB
SCHEMBL5688130 0.84 LTA4H (0.60) LTA4HKDM4EALDH1A1CYP2D6PPARA
SCHEMBL5958258 0.81 ALDH1A1 (0.56) LTA4HALDH1A1CYP2D6MAPTKMT2A
SCHEMBL10307817 0.81 ALOX5 (0.91) LTA4HALOX5OR51E2ALDH1A1CYP2D6
SCHEMBL12018281 0.81 ALOX5 (0.80) LTA4HALOX5OR51E2CYP2D6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed